We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EZA icon
3301
iShares MSCI South Africa ETF
EZA
$578M
$5K ﹤0.01%
96
-2,134
-96% -$108K
FRBA icon
3302
First Bank
FRBA
$454M
$5K ﹤0.01%
449
+369
+461% +$4.07K
GILT icon
3303
Gilat Satellite Networks
GILT
$848M
$5K ﹤0.01%
655
+532
+433% +$4.44K
HYS icon
3304
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
$5K ﹤0.01%
50
ICCC icon
3305
ImmuCell
ICCC
$99.5M
$5K ﹤0.01%
837
+777
+1,295% +$4.54K
IONS icon
3306
Ionis Pharmaceuticals
IONS
$9.4B
$5K ﹤0.01%
83
-1,769
-96% -$115K
ISTR icon
3307
Investar Holding Corp
ISTR
$414M
$5K ﹤0.01%
229
+183
+398% +$4.3K
IXG icon
3308
iShares Global Financials ETF
IXG
$700M
$5K ﹤0.01%
79
IXN icon
3309
iShares Global Tech ETF
IXN
$9.26B
$5K ﹤0.01%
+168
New +$5.11K
LEVI icon
3310
Levi Strauss
LEVI
$9.39B
$5K ﹤0.01%
+241
New +$4.47K
MDWD icon
3311
MediWound
MDWD
$185M
$5K ﹤0.01%
198
-477
-71% -$10.6K
MERC icon
3312
Mercer International
MERC
$39.8M
$5K ﹤0.01%
+408
New +$5.15K
MLAB icon
3313
Mesa Laboratories
MLAB
$574M
$5K ﹤0.01%
21
+17
+425% +$3.93K
MREO
3314
Mereo BioPharma
MREO
$47.3M
$5K ﹤0.01%
1,738
+945
+119% +$2.86K
MSBI icon
3315
Midland States Bancorp
MSBI
$695M
$5K ﹤0.01%
198
-838
-81% -$22K
NAT icon
3316
Nordic American Tanker
NAT
$1.37B
$5K ﹤0.01%
+2,453
New +$4.95K
NBR icon
3317
Nabors Industries
NBR
$1.21B
$5K ﹤0.01%
58
-3,979
-99% -$447K
NFBK
3318
DELISTED
Northfield Bancorp
NFBK
$5K ﹤0.01%
333
-323
-49% -$5.07K
NFJ
3319
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.43B
$5K ﹤0.01%
+408
New +$5.02K
NKSH icon
3320
National Bankshares
NKSH
$268M
$5K ﹤0.01%
+128
New +$4.64K
NNBR icon
3321
NN Inc
NNBR
$311M
$5K ﹤0.01%
+757
New +$5.68K
NSA
3322
DELISTED
National Storage Affiliates Trust
NSA
$5K ﹤0.01%
+160
New +$5.06K
OLP
3323
One Liberty Properties
OLP
$527M
$5K ﹤0.01%
194
-1,255
-87% -$35.2K
OVBC icon
3324
Ohio Valley Banc Corp
OVBC
$205M
$5K ﹤0.01%
+150
New +$5.26K
PIO icon
3325
Invesco Global Water ETF
PIO
$283M
$5K ﹤0.01%
164
+163
+16,300% +$4.52K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.